Panelists discuss several promising new agents for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), including an LPA1 receptor antagonist showing lung function ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback